Daniel Meron

Daniel Meron, Co-Chair of the Healthcare Services & Providers Industry Group and a former high-level official at both the Department of Justice and the Department of Health and Human Services, represents healthcare industry leaders in high-stakes government disputes. He served previously as Global Co-Chair of the firm’s Healthcare & Life Sciences Practice Group.

Daniel leverages an unmatched understanding of the subtleties inherent in litigation involving the DOJ and HHS to represent plans; providers; PBMs; specialty pharmacies; and pharmaceutical, biotech, and medical device manufacturers in:

- False Claims Act (FCA) and related civil investigations

- Legal challenges to the validity of agency regulations and policies

- Providing sophisticated compliance counseling

Daniel joined Latham from the US Department of Health and Human Services (HHS), where he served as General Counsel from 2006 to 2007. He advised department leadership on sensitive and high-priority matters involving all of the key statutes and regulations that HHS enforces, including the Food, Drug, and Cosmetic Act and the Medicare and Medicaid statutes, as well as the federal Anti-Kickback Statute.

As General Counsel, Daniel also worked closely with the Office of Inspector General to coordinate positions on enforcement matters relating to Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) statutes and regulations.

From 2003 to 2006, Daniel was the Principal Deputy Assistant Attorney General for the US Department of Justice’s Civil Division. He oversaw healthcare civil fraud (FCA) and off-label promotion prosecutions, as well as defense of FDA and CMS regulations, policies, and reimbursement decisions.

Daniel served as a law clerk to Justice Anthony M. Kennedy of the US Supreme Court and to Judge Laurence H. Silberman of the US Court of Appeals for the DC Circuit.